THE FUTURE PA Gaines Sheffield Vascular Institute
Outcome dissection Rx by stent-graft 1 year2 years4 years Complication free survival 34 survivors 80%75% Overall complication free survival 69%54% Freedom from re-intervention 88%66% Eggebrecht Eur Heart J 2005
WISH LIST
When to intervene? Coady,MA. J Thor Cardiovasc Surg 1997;113: DescendingAscending All Aneurysms Lower threshold for chronic type B dissection – 5.5cm
Risk Rupture Type B dissection Age COPD Elevated Blood Pressure Juvonen, J thoracic Cardiovasc Surg 1999
Medical Rx type B dissection Genoni,M. Eur J Cardioth Surg 2001;19:606-10
WISH LIST 1.Better pharmaceutical research into inhibiting sack expansion.
Survival following acute type B dissection Umana et al, J Thorac Cardiovasc Surg.2002;124(5): yr 85% 93% 5yrs 71% 91% 10yrs 38% 89% 15yrs 20% Survival Freedom From Surgery Includes IMH
Survival UNCOMPLICATED type B dissection following BMT Winnerkvist et al. 2006;32: INCLUDED IMH
INSTEAD trial Chronic dissections (2weeks – 1yr) 1 yr mortality worse in stent-graft group (10% vs 3%) 11% crossed over from medical group to stent-graft or surgery False lumen thrombosis 95% s/g vs 50% bmt
Features that predict poor outcome Patent false lumen Size > 4cm Largest diameter in the arch of aorta
WISH LIST 1.Better pharmaceutical research into inhibiting sack expansion. 2.Better data - RCT high risk uncomplicated type B - contribution to UK Thoracic Stentgraft Registry
COMPLICATIONS Stroke Paraplegia Renal failure Access site and iliac artery Retrograde propagation of dissection
BETTER DEVICES Smaller diameter Compliance better matched to the pathology Branched Better deployment
WISH LIST 1.Better pharmaceutical research into inhibiting sack expansion. 2.Better data - RCT high risk uncomplicated type B - contribution to UK Thoracic Stentgraft Registry 3. Better devices
Chronic Dissection Eggebrecht Eur Ht J of 28 pts (11%) sustained fatal rupture of the TAA during FU median 18 months
Yearly risk
Chronic Dissection Eggebrecht Eur Ht J of 28 pts (11%) sustained fatal rupture of the TAA during FU median 18 months WHY?
Chronic Dissection ACUTE CHRONIC DIAMETER FALSE LUMEN
Chronic dissection
WISH LIST 1.Better pharmaceutical research into inhibiting sack expansion. 2.Better data - RCT high risk uncomplicated type B - contribution to UK Thoracic Stentgraft Registry 3.Better devices 4.New paradigms for the endovascular management of chronic dissection
PETTICOAT
Incidence of aneurysms after type 1 and type 3 dissection Probability of aneurysm best predicted by diameter false lumen > 22 mm at presentation Song, JACC 2007
False lumen patency 6 of 51 type 1 thrombosed 3 of 47 type 3 thrombosed Song, JACC 2007
Yearly risk
Expansion Rates Normal aorta 0.09 cm/year Aneurysmal Aorta 0.1 – 0.2 cm/yr Dissected aorta 0.28 – 0.56 cm/yr Coady,MA. J Thor Cardiovasc Surg 1997;113:476-91
Chronic Dissection DIAMETER WHOLE AORTA
Chronic vs Acute Dissection type B SURVIVAL Eggebrecht Eur Ht J 2005